KATHRYN DREVETS: Open Payments
NPI 1235551623 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,051 in 42 payments from 11 companies in 2025. Trend: 2023 $470 · 2024 $659 · 2025 $1,051
Food & beverage: $1,051
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $470 |
| Gilead Sciences, Inc. | 14 | $261 |
| Ipsen Biopharmaceuticals, Inc | 4 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Davol Inc. | 1 | $27 |
| Eton Pharmaceuticals, Inc. | 1 | $24 |
| Veloxis Pharmaceuticals, Inc. | 1 | $20 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, LIVTENCITY, GALZIN, ENVARSUS, OCALIVA, Livmarli.
Industry payments across OK — which companies pay providers there.
